# Sevoflurane and Propofol for Botulinum Toxin Injection

> **NCT05505123** · NA · WITHDRAWN · sponsor: **Yeungnam University College of Medicine**

## Conditions studied

- Cerebral Palsy

## Interventions

- **DRUG:** Sevoflurane
- **DRUG:** Propofol

## Key facts

- **NCT ID:** NCT05505123
- **Lead sponsor:** Yeungnam University College of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-08-26
- **Primary completion:** 2022-12-09
- **Final completion:** 2022-12-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No participants enrolled
- **Last updated:** 2023-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05505123

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05505123, "Sevoflurane and Propofol for Botulinum Toxin Injection". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05505123. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*